<DOC>
	<DOCNO>NCT00509535</DOCNO>
	<brief_summary>Atopic dermatitis ( AD ) , chronic relapse inflammatory skin disease , associate elevate IgE level Th2 response . It currently believe non-pathogenic bacteria modulate intestinal immune response avoid development allergic disease . However , effect oral probiotic AD could reproduce study direct immuno-modulation skin associate immune response non-pathogenic bacteria investigate far . We therefore perform double blind placebo control clinical study effect ointment contain 5 % extract non-pathogenic bacteria Vitreoscilla filiformis AD . Seventy-five AD patient ( 6-70 year age ) randomize receive either Vitreoscilla filiformis ointment 5 % vehicle ointment daily 30 day . Efficacy evaluation , include `` Score Atopic Dermatitis '' ( SCORAD ) , transepidermal water loss , assessement microflora , patient assessment itch loss sleep occur baseline , day 15 , day 29 .</brief_summary>
	<brief_title>Prospective , Randomized , Double Blind Comparative Study Use Two Creams Xerosis Atopic Probands</brief_title>
	<detailed_description>Atopic dermatitis ( AD ) chronically relapse inflammatory skin disease often coexist atopic disease , allergic rhinitis , conjunctivitis asthma ( Biedermann Röcken 1999 , Biedermann et al . 2001 , 2004 , 2006 ; Leung et al. , 2000 , 2003a , 2003b ) . Even though immune pathology AD precisely understand , today new concept atopic dermatitis pathology base large set data . In patient AD , dry skin dysfunction epidermal barrier find . As important prove concept , loss function mutation epidermal protein filaggrin impair skin barrier function find detect 15 % kaukasian AD patient ( Palmer et al. , 2006 ) . As consequence , patient AD predispose develop sensitization dominate Th2 immune phenotype ( Hudson , 2006 ) . Independently filaggrin study , demonstrate earlier disrupt barrier function stratum corneum present atopics involve skin , also uninvolved dry skin facilitate permeation various environmental substance skin ( Berardesca et al. , 1990 ; Werner et al. , 1985 ; Watanabe et al. , 1991 ; Loden et al , 1992 ) . As biomarker , increase level transepidermal water loss ( TEWL ) demonstrate ( Tagami et al. , 1985 ; Ghadially et al. , 1996 ) . Various functional morphological study atopic xerosis clinically appear without inflammation demonstrate cellular inflammation already present atopic skin key initial step development atopic dermatitis ( Watanabe et al. , 1991 ; Uehara et al. , 1984 ) . In fact , barrier dysfunction , atopic immune dysregulation , atopic dermatitis pathogenesis independent event , closely link ( Biedermann 2006 ; Hudson 2006 ) . Th2 lymphocytes dominate atopic immune phenotype underlie cell type responsible induction IgE antibody ( Biedermann et al . 1999 , 2004 ) . Barrier dysfunction predisposes development Th2 lymphocytes Th2 cell first cell type invade atopic skin initiate inflammation inflammatory vicious circle inflammation ( Biedermann 2002 ; 2004 ; Lametschwandtner et al . 2004 ; Günther et al . 2005 ) . Next Th2 lymphocytes , atopic dermatitis skin lesion , infiltrates eosinophils cell mononuclear phagocyte lineage find . The altered skin structure people atopic predisposition allows increase penetration allergen irritative substance ( Roll et al. , 2004 ; Hudson 2006 ) . Many study show extent S. aureus colonization correlate AD disease activity ( Cho et al. , 2001 ; Biedermann 2006 ) . In 90 % AD patient , massive skin colonization S. aureus ( 107cfu/cm2 lesional skin ) find ( Matsui et al. , 2000 ) . A prerequisite bacterial colonisation genuine barrier dysfunction , mechanical disruption barrier trigger inflammation ( scratch ) , alkaline pH , decrease IgA secretion sweat production , predominant Th2 cell inhibit anti-infectious immune response , reduce antimicrobial peptide , represent important pathophysiological feature lead disruption primary skin defense system ( Biedermann et al . 2001 ; Biedermann &amp; Röcken 2001 , ; Biedermann et al . 2002 ; Biedermann 2006 ; Howell , 2005 ; Rieg 2005 ) . Among several microbe colonise skin , bacterium Staphylococcus aureus ( S. aureus ) may play important role pathogenesis dermatitis atopic people ( Biedermann 2006 ) . This colonization observe involved inflammatory skin also non involved dry skin . The ratio Staphylococcus aureus / Staphylococcus epidermidis inverse comparison healthy skin . Many study show extent S. aureus colonization correlate AD disease intensity ( Cho et al. , 2001 ) . Reduced expression antimicrobial peptide demonstrate AD skin favour colonization S. aureus ( Ong et al . N. Engl . J. Med . 2002 ; Howell et al.. Immunity . 2006 ; 24:341-8 ; Rieg et al . JI 2006 ) . In addition , dry skin may allow colonization bacteria S. aureus . Decreased level sphingosine , antimicrobial property fact S. aureus stimulate hydrolysis ceramides bacterial derive ceramidase atopic skin add dysfunction immune barrier AD ( Arikawa et al. , 2002 ; Kita et al , 2002 ) . The cell membrane S. aureus contain adhesins epidermal dermal laminin fibronectin allow attachemment S. aureus . skin dock position S. aureus uncover lesional skin ( Cho et al , 2001 ) . The precise mechanism S. aureus gain access dermis unknown , suggest IL-4 , produce T helper type 2 cell , induces fibronectin synthesis , combination plasma exsudation fibrinogen , allow S. aureus bind skin . Moreover , S. aureus able encase kind biofilm compose hydrate matrix polysaccharide ( glycocalix ) proteins , support cell adhesion ( Akiyama et al. , 2003 ) . After colonization , S. aureus contributes skin inflammation e.g . secrete toxin array call pathogen associate molecular pattern ( PAMP ) bind pathogen recognition receptor Toll- like receptor directly trigger inflammation ( Biedermann 2006 ) . Moreover , S. aureus PAMPs also influence T cell mediate skin inflammation indirectly regulate skin home T cell orchestrate chronic inflammation AD skin ( Biedermann 2006 ; Biedermann et al . 2006 ) . Vitreoscilla filiformis ( Vf ) ( ATCC15551 ) use study non-photosynthetic , non-fruiting gliding bacteria define accord classification Bergey 's ( 1989 ) . This filamentous bacterium belongs order Beggiatoales . It micro-organism find sodic sulphuretted thermal spring recognize local anti-pruriginous anti-inflammatory property . The micro-organism Vitreoscilla filiformis ( Vf ) cultivate define sterile medium , expand isolated constitute biomass call `` pure extract thermal plankton '' . The term plankton describe zooplankton ( chemiotrope microorganism ) contrast phytoplankton ( phototrope microorganism ) . At end culturing , biomass concentrate stabilized centrifugation autoclave . The technical preparation sterile aqueous suspension plankton . In vitro study show plankton support production collagen fibroblast reinforce antioxidant system ; prevents Langerhans cell alteration ( reconstruct skin organotypic skin culture ) expose UVB . It exhibit non-specific immunomodulatory effect cellular immunity particular macrophage ( Patent US , 6,190,671 B1 ; US , 6,242,229 B1 ; WO-94/02158 ) . Preclinical study show extract anti-inflammatory activity ( decrease ear oedema acid arachidonic treatment modulates contact hypersensitivity reaction oxazolone ) . Moreover , new compound promote heal epidermis dermis ( scar follow suction blister follow incision preclinical study ; Patent US , 6,190,671 B1 ) . Therefore , new compound promise alleviate infection usually find skin skin burning , protect skin ultraviolet alteration display moisturize property skin . Clinical trial show bacterial extract Vitreoscilla filiformis effective acne seborrhoeic dermatitis promote moisturization skin ( study Seoul , Korea Nice , France patent FR-2,283 , 223 ) show beneficial sensitive skin ( clinical trial Dr Desruelle F Nice , France ) Moreover , randomize , double-blind , placebo-controlled trial formulate 5 % extract Vitreoscilla filiformis symmetric active lesion AD accord split-body design perform Prof. J. F. Nicolas Lyon , France . In study , treatment ( applied twice daily ) cream contain 5 % Vitreoscilla filiformis extract find safe well tolerate . Moreover , extract significantly alleviate AD old child ( 7 year old ) adult compare vehicle treatment ( p=0.008 ; Wilcoxon sign rank test ) . The therapeutic effect extract observe within second week application steadily increase thereafter . This effect cream contain 5 % Vitreoscilla filiformis extract appear rapid onset especially regard pruritus demonstrate use mEASI index . Paired test confirm significant difference decrease pruritus 5 % Vitreoscilla filiformis extract treated side day 28 ( p=0,046 , Wilcoxon exact sign rank test ) . ( Gueniche et al . 2006 ) . Our task perform double blind randomize prospective study compare 5 % Vitreoscilla filiformis extract ( cream B ) whith vehicle ( cream A ) include measurement biometric change occur use two cream . During study biometrical clinical measurement include transepidermal water loss , qualification quantification skin microflora clinical evaluation skin finding , use cream document . Further proband ` experience use cream assess . Biometric variable skin determine , use cream A cream B . The transepidermal water loss biometrical value estimate assess skin barrier function visit . We evaluate topical application cream A cream B influence microflora skin atopic volunteer . Qualification quantification several bacteria ( S. aureus , S. epidermis , P. acne , Streptococci , E. coli ) perform , end study period . In addition , intensity pruritus clinical aspect skin assess . At end study volunteer fill questionnaire ask oiliness , distribution , consistency adsorption cream .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Patients mild atopic dermatitis include . The eczematous lesion may pass 5 % total body surface . The lesion may weep . Past history severe scar skin surgery Past history cutaneous cancer , malignant melanoma Patient show lack compliance Currently participate participate another clinical trial last 3 month prior begin study Allergy incompatibility one component cream Pregnant breast feading woman Retraction write informed consent Patients keep untreated topical steroid include . Patients severe infect atopic dermatitis exclude patient conventional antiinflammatory therapy withdrawn exclude</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Vitreoscilla filiformis extract</keyword>
	<keyword>SCORAD</keyword>
	<keyword>pruritus</keyword>
	<keyword>microflora</keyword>
	<keyword>TEWL</keyword>
</DOC>